TFX Q3 2025 Earnings — Teleflex Incorporated Revenue & Financial Results | Market Cap Arena

TFXTeleflex Incorporated

$5B

Q3 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$913M+19.4% YoY

Gross Profit

$452M49.5% margin

Operating Income

-$30M-3.3% margin

Net Income

-$409M-44.8% margin

EPS (Diluted)

$-9.24

QoQ Revenue Growth

+16.9%

Cash Flow

Operating Cash Flow

$108M

Free Cash Flow

$78M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$7.9B

Total Liabilities

$4.1B

Stockholders' Equity

$3.8B

Cash & Equivalents

$354M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$913M	$764M	+19.4%
Gross Profit	$452M	$430M	+5.0%
Operating Income	-$30M	$149M	-119.9%
Net Income	-$409M	$111M	-468.4%

Revenue Segments

Interventional

$266M32%

Vascular Access

$191M23%

Surgical

$123M15%

Anesthesia

$101M12%

Other

$79M9%

Interventional Urology

$72M9%

Geographic Segments

Americas Segment

$556M61%

EMEA

$234M26%

Asia

$123M13%